These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8140382)
1. Effect of vasoconstrictor pre-treatment on obstruction, secretion and sneezing after nasal challenge with threshold and suprathreshold allergen doses. Brooks CD; Karl KJ; Francom SF Rhinology; 1993 Dec; 31(4):165-8. PubMed ID: 8140382 [TBL] [Abstract][Full Text] [Related]
2. Reproducibility of nasal allergen challenge in evaluating the efficacy of intranasal corticosteroid treatment. Proud D; Riker DK; Togias A Clin Exp Allergy; 2010 May; 40(5):738-44. PubMed ID: 20337650 [TBL] [Abstract][Full Text] [Related]
3. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis]. Tahamiler R; Saritzali G; Canakçioğlu S Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609 [TBL] [Abstract][Full Text] [Related]
5. Important roles of tachykinins in the development of allergic nasal hyperresponsiveness in guinea-pigs. Nabe T; Tsuzuike N; Ohtani Y; Mizutani N; Watanabe S; Fujii M; Yoshimura M; Nagasawa M; Kohno S Clin Exp Allergy; 2009 Jan; 39(1):138-46. PubMed ID: 18778270 [TBL] [Abstract][Full Text] [Related]
6. Study of nasal cytology in atopic patients after nasal allergen challenge. Wang D; Clement P; De Waele M; Derde MP Rhinology; 1995 Jun; 33(2):78-81. PubMed ID: 7569656 [TBL] [Abstract][Full Text] [Related]
7. The effect of budesonide on nasal allergen challenge in patients with seasonal rhinitis and on nasal peak flow in healthy volunteers. Munch EP; Weeke B; Johansson SA Eur J Respir Dis Suppl; 1982; 122():176-84. PubMed ID: 6958483 [TBL] [Abstract][Full Text] [Related]
8. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses. Parameswaran K; Fanat A; O'Byrne PM Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243 [TBL] [Abstract][Full Text] [Related]
9. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge. Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650 [TBL] [Abstract][Full Text] [Related]
10. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338 [TBL] [Abstract][Full Text] [Related]
11. Effect of systemically administered H1- and H2-receptor antagonists on nasal blood flow as measured with laser Doppler flowmetry in a provoked allergic reaction. Juliusson S; Bende M Rhinology; 1996 Mar; 34(1):24-7. PubMed ID: 8739864 [TBL] [Abstract][Full Text] [Related]
12. Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. Vishwanath S; Baroody FM; Chaaban MR; deTineo M; Lasser KH; Lasser EC; Naclerio RM J Allergy Clin Immunol; 2011 Jul; 128(1):219-21. PubMed ID: 21414657 [No Abstract] [Full Text] [Related]
13. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883 [TBL] [Abstract][Full Text] [Related]
14. Effects of intranasal azelastine on the response to nasal allergen challenge. Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037 [TBL] [Abstract][Full Text] [Related]
15. Unilaterality of obstruction after acute nasal allergen provocation. Relation of allergen dose, nasal reactivity and the nasal cycle. Brooks CD; Karl KJ; Francom SF Clin Exp Allergy; 1991 Sep; 21(5):583-7. PubMed ID: 1742650 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of early phase congestion after nasal allergen provocation. Gotlib T; Samoliński B; Grzanka A; Balcerzak J Rhinology; 2008 Mar; 46(1):52-5. PubMed ID: 18444493 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930 [TBL] [Abstract][Full Text] [Related]